PHIA Koninklijke Philips N.V.

Philips Sounds transform the sound of care, reducing patient monitoring alarm noise by up to 66%

Philips Sounds transform the sound of care, reducing patient monitoring alarm noise by up to 66%

February 6, 2024

FDA 510(k) clearance of latest Philips IntelliVue patient monitor software helps drive alarm management strategies toward a more peaceful, healing environment for patients and caregivers

Amsterdam, the Netherlands – Advances in healthcare technology continue to drive patient monitoring technology into the future; however, alarm sounds have remained similar, if not unchanged, for many years. Until now.  (NYSE: PHG, AEX: PHIA), has received 510(k) clearance for its latest IntelliVue patient monitor software, which features the long-anticipated availability of several new solutions, including the Philips Sounds alarm package, making it available in the USA and more than 200 countries worldwide.

Noise in hospitals can impact the quality of life and health of patients, their families, and their care providers. In the average ICU, patient monitors account for up to 82% of alarm tones [1] with up to 350 alarms per patient every day [2]. While alarms function to gain attention, over time the sheer number of them can wear down caregivers [3] and contribute to the anxiety of patients and their families [4]. To help drive alarm management strategies toward a more peaceful, healing environment for patients and caregivers alike, Philips has applied a fresh perspective to acute patient monitor alarm sounds by collaborating with clinicians and world-leading sound experts.

“While alarms in acute care settings must be effective, they should be sensible, informative, and respectful of the surrounding environment and the people in it,” says Christoph Pedain, Business Leader, Hospital Patient Monitoring, Philips. “Throughout the process, we asked for input from care providers, administrators, patients and their families who are exposed to these alarms regularly and leveraged powerful data to help improve the experience overall.”

The IntelliVue alarm evolution involved a significant research investment to capture and implement input from care providers and patients in alarm-heavy environments. Together, Philips and the sound design group SenSound worked to soften and round the alarm tones and adjust alarm intervals to more gently signal status or request action using a more soothing – yet still impactful – set of alarm sounds. These changes are designed to help improve the patient and caregiver experience. Philips’ new patient monitoring sounds have been proven to reduce alarm noise by up to 66% [5].

“Alarm management within the hospital setting is complicated and multifaceted, and even the smallest change will have an enormous impact,” says Andreas Walden, Usability Leader, Hospital Patient Monitoring at Philips. “When we think about medical alarms generally, we make sure they are audible, prompt action, and can be differentiated from other sounds. But we haven’t asked questions like ‘Is this something a nurse on a 12-hour shift should hear every day?’ or ‘Can a sick patient hear this without getting scared?’ The ability to address those concerns is the beginning of transforming the entire soundscape in the hospital.”

With over one million IntelliVue patient monitors in use [6], the evolution of our monitor sounds means the potential to enhance and change the soundscape in healthcare facilities worldwide, helping to advance the healing environment for both patients and hospital staff.

Beyond the sound of care

Additional noteworthy capabilities within the new IntelliVue software update, including , are now available in the USA and more than 200 countries worldwide. For more information about Philips’ portfolio of alarm management solutions, visit or contact your regional sales rep for local availability.

[1] Cho, O. M., Kim, H., Lee, Y. W., & Cho, I. (2016). Clinical Alarms in Intensive Care Units: Perceived Obstacles of Alarm Management and Alarm Fatigue in Nurses. Healthcare Informatics Research, 22(1), 46–53.

[2] Jones K. (2014). Alarm fatigue a top patient safety hazard. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne, 186(3), 178.  /10.1503/cmaj.109-4696.

[3] Topf & Dillon, 1988; Topf, 2000; Morrison et al., 2003; Ryherd et al., 2008; J. P. Keller et al., 2011; Watson et al., 2015; Cho et al., 2016.

[4] Topf, 2000; Basner, 2011; Shivers et al., 2013; Basner et al., 2014; Sakallaris et al., 2015; Sen & Sen, 2020

[5] Compared to previous Philips alarm sounds as it relates to intervals. The Philips 2021 interval for cyan alarms is every 2 seconds compared to every 6 seconds with traditional sounds.

[6] Based in internal sales data.

For further information, please contact:

Meredith Amoroso

Philips Global Press Office

Tel:

E-Mail:

About Royal Philips 

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at . 

Attachments



EN
06/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips launches RADIQAL study to generate real-world evidence for new...

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the USPrimary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the (R...

 PRESS RELEASE

Philips launches real-time 3D intracardiac imaging in Europe, expandin...

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real timeCatheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – (NYSE: PHG...

 PRESS RELEASE

Philips successfully prices offering of Notes for EUR 1 billion to be ...

Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects May 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes due 2035 (the “Notes”) under its European Medium Term Note (EMTN) program. The net proceeds will be used for general corporate purposes, the repayment of 2026 debt maturities, and to refinance or finance any ...

 PRESS RELEASE

Philips Future Health Index 2025: AI poised to transform global health...

Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, , highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. H...

Koninklijke Philips N.V.: 1 director

A director at Koninklijke Philips N.V. bought 8,176 shares at 24.410USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch